Medical Devices


  • People seen walking down Wall Street.
    Image attribution tooltip
    Spencer Platt via Getty Images
    Image attribution tooltip

    M&A and a separation take center stage in latest earnings season

    BD announced it would split from its biosciences and diagnostics unit, while Zimmer Biomet updated investors on its $1.1 billion buy of Paragon 28.

    By Feb. 10, 2025
  • FDA headquarters with sign in foreground
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA posts early alert about BD device linked to 30 injuries, 4 deaths

    The alert was posted one day after BD sent customers a letter warning about the risk of atherectomy catheters breaking.

    By Feb. 10, 2025
  • Close up of hand touching smartwatch with health app on the screen. Explore the Trendline
    Image attribution tooltip
    Sitthiphong via Getty Images
    Image attribution tooltip
    Trendline

    Medical device industry continues to turn to AI

    While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.

    By MedTech Dive staff
  • A photo of Thermo Fisher's manufacturing facility in Plainville, Massachusetts.
    Image attribution tooltip
    Courtesy of Thermo Fisher Scientific
    Image attribution tooltip

    Thermo Fisher lays off another 300 workers in Massachusetts

    Job cuts in Cambridge and Plainville are the second workforce reduction planned for the facilities in the past three months.

    By Feb. 7, 2025
  • Becton Dickinson logo
    Image attribution tooltip
    Permission granted by Becton Dickinson
    Image attribution tooltip

    BD plans split from life science business to fuel medtech investment

    CEO Tom Polen said BD will “double down on shifting our portfolio, both organically and inorganically through tuck-in M&A, into higher-growth, high-margin accretive growth spaces.”

    By Feb. 7, 2025
  • A metal, rounded device says "Senza Omnia" and has two attached leads.
    Image attribution tooltip
    Courtesy of Nevro
    Image attribution tooltip

    Globus to buy Nevro for $250M

    Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale and orthopedic relationships.

    By Feb. 6, 2025
  • Professional photo of Ivan Tornos
    Image attribution tooltip
    Permission granted by Zimmer Biomet
    Image attribution tooltip

    Zimmer touts ASC opportunity with Paragon 28 purchase

    With the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, extremities and trauma segment will outpace hips and knees.

    By Feb. 6, 2025
  • Professional photo of Orleigh Bogle
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip
    Q&A

    Medtronic’s Orleigh Bogle on changing the culture of surgical training

    Bogle, Medtronic’s head of medical affairs for digital surgery, also discussed the company’s plans to train surgeons for its Hugo surgical robot.

    By Feb. 6, 2025
  • A nurse is seen caring for a patient just out of view.
    Image attribution tooltip
    Brandon Bell / Staff via Getty Images
    Image attribution tooltip

    AHA joins call for Trump to exempt devices from import tariffs

    Disruption to the supply of devices from China would curtail hospitals' ability to perform life-saving surgeries and protect patients and healthcare workers from contagion, the group warned.

    By Feb. 6, 2025
  • Recruitment or leadership concept. People row with spotlight highlighted one - creative visualization of people challenge competition
    Image attribution tooltip
    Getty Images via Getty Images
    Image attribution tooltip

    Pulse Biosciences names new CFO, continuing string of C-suite changes

    Pulse, which named a new CEO last month, is pitching its pulsed field ablation technology as a way to shorten procedure times.

    By Feb. 5, 2025
  • Photo of Michael F. Mahoney, CEO of Boston Scientific.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific closes its year of PFA on a high note

    Farapulse, Boston Scientific’s pulsed field ablation product, fueled year-over-year growth of nearly 171% in the fourth quarter for the company’s electrophysiology group.

    By Feb. 5, 2025
  • A truck drives past a row of containers on rail cars.
    Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    Illumina placed on China’s unreliable entity list

    Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s genome sequencing market.

    By Feb. 5, 2025
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic recall of brain fluid drainage systems linked to 15 injuries

    The company will keep the systems on the market but is asking providers to check devices for visible cracks and return affected devices.

    By Feb. 4, 2025
  • Robert F. Kennedy Jr. sits behind a desk in a Senate hearing room.
    Image attribution tooltip
    Win McNamee via Getty Images
    Image attribution tooltip

    RFK Jr. clears key hurdle on path to HHS secretary

    A key Senate committee voted to advance Robert F. Kennedy’s nomination even after some legislators raised concerns about his previous vaccine stances and confusion surrounding programs like Medicare and Medicaid.

    By Sydney Halleman , Delilah Alvarado , Jonathan Gardner • Feb. 4, 2025
  • The Olympus U.S. headquarters building is shown against a clear blue sky.
    Image attribution tooltip
    Retrieved from Olympus on February 03, 2025
    Image attribution tooltip

    FDA labels recall of discontinued Olympus endoscope part as Class I

    The update comes about six weeks after an early alert flagged reports of 120 injuries and one death linked to reprocessing of the device.

    By Feb. 3, 2025
  • Tractor-trailers emerge from under an overpass while traveling side by side in a city landscape of Detroit.
    Image attribution tooltip
    ChrisBoswell via Getty Images
    Image attribution tooltip

    Advamed pushes for medical device exemption from Trump tariffs

    CEO Scott Whitaker said “an exemption was provided for most medical devices during President Trump’s first term with respect to the tariffs on China, and we are advocating for a similar approach.”

    By Feb. 3, 2025
  • Professional photo of Joe Almeida
    Image attribution tooltip
    Permission granted by Baxter
    Image attribution tooltip

    Baxter CEO José Almeida retires

    Brent Shafer, Baxter’s lead independent director, will serve as interim CEO. The company also promoted Heather Knight to chief operating officer.

    By Feb. 3, 2025
  • donald trump signs an executive order at his desk
    Image attribution tooltip
    Anna Moneymaker via Getty Images
    Image attribution tooltip

    Trump issues tariffs on Canada, Mexico and China

    The president ordered an additional 10% duty on goods from China and 25% tariffs on imports from Canada and Mexico, though Canadian energy resources will face a lower rate.

    By Philip Neuffer • Updated Feb. 1, 2025
  • A person sits on a white couch and speaks.
    Image attribution tooltip
    Elise Reuter/MedTech Dive
    Image attribution tooltip

    Troy Tazbaz, CDRH digital health leader, resigns

    Tazbaz was director of the FDA’s Digital Health Center of Excellence for two years, leading key policies on artificial intelligence and software as a medical device.

    By Jan. 31, 2025
  • A picture of the surgeon's console for Intuitive Surgical's da Vinci 5 surgical robot.
    Image attribution tooltip
    Courtesy of Intuitive Surgical
    Image attribution tooltip
    2025 outlook

    Top medtech trends in 2025: New products and M&A are bright spots, but Trump brings uncertainty

    Experts highlighted surgical robotics, artificial intelligence and M&A as top trends this year. However, the Trump administration could create challenges for the industry.

    By Jan. 31, 2025
  • People clap and cheer behind a podium with the words "Nasdaq."
    Image attribution tooltip
    Retrieved from Nasdaq on January 31, 2025
    Image attribution tooltip

    Beta Bionics raises $204M in IPO

    The diabetes tech firm began trading this week and was valued at $966.2 million as of Thursday.

    By Jan. 31, 2025
  • A sign reading Food and Drug Administration is seen above a door to a government building.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA warns about patient monitor cybersecurity vulnerabilities

    Vulnerabilities in certain Contec and Epsimed patient monitors can allow people to gain access and potentially manipulate the devices, the FDA warned.

    By Jan. 31, 2025
  • A picture of Getinge's headquarters building in Gothenburg, Sweden.
    Image attribution tooltip
    Courtesy of Getinge
    Image attribution tooltip

    Getinge exits surgical perfusion, creating opportunity for Livanova

    Getinge CEO Mattias Perjos said surgical perfusion has “been a struggling category” since an FDA consent decree forced the company off the U.S. market in 2015.

    By Jan. 30, 2025
  • The White House in Washington, D.C.
    Image attribution tooltip
    Alex Wong via Getty Images
    Image attribution tooltip

    White House rescinds memo pausing federal funding following pushback

    The Office of Management and Budget rolled back a memo halting federal funding that caused widespread confusion and alarm. But “this is NOT a rescission of the federal funding freeze,” Trump’s top press secretary said.

    By Rebecca Pifer • Jan. 29, 2025
  • Multiple black-and-white scans of the lumbar spine next to each other.
    Image attribution tooltip
    HadelProductions via Getty Images
    Image attribution tooltip

    Stryker to sell spinal implants business

    The company named a new CFO and shared an update on its planned Inari Medical acquisition.

    By Jan. 29, 2025
  • A surgeon using a davinci intuitive robot
    Image attribution tooltip
    Courtesy of Intuitive
    Image attribution tooltip
    Deep Dive // 2025 outlook

    4 robotic surgery trends to watch in 2025

    Intuitive Surgical will face competition this year from Medtronic and smaller companies like CMR Surgical and Moon Surgical coming to the U.S. market with robotic surgery systems.

    By Jan. 29, 2025